
What The COVID-19 Self-Test Kit Means for Employers & Employees
On November 17, 2020, the FDA issued emergency use authorization (EUA) for the first self-test kit for COVID-19 that can provide rapid results at home with 94%-98% accuracy.
While Lucira’s single-use test is currently only available at Sutter Health in Northern California and the Cleveland Clinic in South Florida, it is expected to be available nationwide in early 2021. The test kit – estimated to cost around $50 – will require a prescription and all results must be reported to health authorities. Individuals over the age of 14 who are showing symptoms of COVID-19 will be able to self-administer the test and get results at home within 30 minutes. The test is also authorized for use in doctor’s offices, hospitals, urgent care centers and emergency departments for patients of all ages. Continue reading